CRL · 8-K · 20261109PR017127

Bioanalysis Market Demand

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-11-09 · Importance 22 · Surprise 32

Charles River describes bioanalysis as a long-term growth opportunity, citing demand for additional scientific data and specialized assays as biologics, complex modalities, and advanced therapies expand. It estimates the bioanalysis market will grow from approximately $6 billion in 2026 to $8 billion–$9 billion in 2031, a projected annual growth rate of 6%–8%. The company says growth is expected to be higher in biologics, complex modalities, and clinical-phase testing.

Key facts

• The bioanalysis market is expected to grow from approximately $6 billion in 2026 to approximately $8 billion to $9 billion in 2031, representing annual growth of 6% to 8%. source
• Charles River expects revenue of the acquired businesses to grow at the projected bioanalysis sector growth rate over the next five years. source
• Higher bioanalysis market growth is expected in biologics and complex modalities, as well as for clinical-phase testing. source